logo
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
logo
CONTACT US
CALL US
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us

Home » Motion Filed to Consolidate Lipitor Diabetes Lawsuits

Motion Filed to Consolidate Lipitor Diabetes Lawsuits

Attorneys for three women who claim they developed type 2 diabetes after taking the cholesterol-lowering drug, Lipitor, have filed a motion to consolidate all lawsuits filed against Pfizer, the manufacturer of Lipitor, in a South Carolina federal court. The consolidation of these lawsuits, commonly referred to as multidistrict litigation (MDL), allows all pre-trial proceedings to be centralized before one judge. This helps to provide consistency in court rulings and a conservation of resources for all parties involved in the litigation.

The FDA issued a safety warning in February 2012 for Lipitor and other statin drugs after studies revealed thatwomen taking Lipitor have an increased risk for developing type 2 diabetes mellitus. The study specifically noted that women with a body mass index of 25 or under, considered ‘normal’ weight range per CDC standards, ran the highest risk for developing high blood sugar levels and diabetes.

Our product liability attorneys are currently speaking to women who have taken Lipitor and have developed type 2 diabetes. If you or someone you care about is a woman who has been taking Lipitor for the treatment of high cholesterol and has developed type 2 diabetes, contact us. Our product liability attorneys have litigated thousands of claims against pharmaceutical and medical device manufacturers and can advise you of your legal rights and options. Complete your free Lipitor case evaluation here.

Contact Us

One Indiana Square Suite 1400
Indianapolis, Indiana 46204

Copyright ©  Cohen & Malad, LLP. All rights reserved.

Disclaimer  |  Privacy Policy

 

Schedule a free consultation Today
  • This field is for validation purposes and should be left unchanged.

Schedule a free consultation Today

  • This field is for validation purposes and should be left unchanged.

ALERTS

Former NFL Players Still Have Time to Claim Concussion Settlement Funds

It’s not too late for former National Football League players to claim their funds from the concussion .. Read More

SEE ALL ALERTS

In the News

Indiana Legal Services and Indiana State Bar Foundation Receive $90,000 donation from Cohen & Malad, LLP Class Action United Way of Central Indiana’s Center for Working Families Receives $32,000 from Cohen & Malad, LLP Settlement Funds Indianapolis Neighborhood Housing Partnership Receives $32,000 from Cohen & Malad, LLP Settlement Funds
READ OUR NEWS